Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated tar ...

A third option is suppression: the United States would forgo development of ASI and stop anyone else from building it on the basis that superintelligence is just too dangerous to be unleashed on the ...

Recursion, Roche, and its Genentech subsidiary have announced plans to co-develop a neuroscience discovery program based on ...

Recursive’s $400 million outlay represents the bulk of the company’s fundraising to date.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an ...

JavaScript Explicit Resource Management lands in Safari Technology Preview 250, completing cross-browser support across V8, ...

Microsoft Threat Intelligence examines DeadLock ransomware, an emerging financially motivated operation distinguished by its ...

They say everything is bigger in Texas, and if you take into account all that the state has to offer, it's easy to see why the Lone Star State packs such a potent punch with travelers. Texas is filled ...

For some, escaping the daily grind means getting their adrenaline pumping on a rugged mountainside or 50 feet below the ocean's surface. Others search for snowy peaks and alpine lakes simply for a ...

A wisely crafted investment portfolio can build tremendous wealth over time. Investing money the right way can help send your kids to college, plan for a comfortable retirement, or meet any other ...